Barrack: Trump's Executive Orders Are Creating Dialog

The transcript discusses the President's direct interventions in various industries, including Lockheed, Boeing, GM, and pharmaceuticals. It highlights the challenges in the pharmaceutical payment system, focusing on Medicare and private insurers. The President's approach to government accountability is examined, emphasizing his unusual methods. The transcript also explores the President's strategy against lobbyists and special interests, aiming to change the dialogue and vocabulary. Finally, it addresses the tension between constituency expectations and business views, questioning whether CEOs are genuinely changing their behavior or if it's merely spin.

In what ways might the president's executive orders reflect his promises to the constituency?

What impact might the president's actions have on CEO behavior in response to his interventions?